GSTM1 and metabolic disease: Besides, a considerable increase in liver dimensions in the fetus is a good indicator of the severity, the clinical outcome in pregnancies with Rh isoimmunization, Hb Bart’s disease, congestive heart failures, certain metabolic diseases, tumors, and even intrauterine infections [1, 3, 13, 14, 20].